Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study (Q44503536)
Jump to navigation
Jump to search
scientific article published in June 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study |
scientific article published in June 2003 |
Statements
1 reference
Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study (English)
1 reference
Bruce M Spiegelman
1 reference
Harold J Burstein
1 reference
Eric P Winer
1 reference
George D Demetri
1 reference
Elisabetta Mueller
1 reference
Pasha Sarraf
1 reference
1 June 2003
1 reference
1 reference
1 reference
Identifiers
1 reference